About Amprion
Amprion is a company based in Houston (United States) founded in 2006. It operates as a HealthTech. Amprion has raised $11.76 million across 8 funding rounds from investors including Lilly, HHS and Foundry. Amprion offers products and services including SAAmplify-αSYN. Amprion operates in a competitive market with competitors including ADx NeuroSciences, Cytox, PeopleBio R&D, Durin Technologies and ALA Diagnostics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amprion Diagnostics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.76 M (USD)
in 8 rounds
-
Latest Funding Round
$6 M (USD), Series B
Oct 10, 2024
-
Investors
Lilly
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amprion
Amprion offers a comprehensive portfolio of products and services, including SAAmplify-αSYN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A test detecting pathological α-synuclein in CSF samples.
Unlock access to complete
Funding Insights of Amprion
Amprion has successfully raised a total of $11.76M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $6.0M
-
First Round
First Round
(16 May 2012)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Amprion | Valuation | unknown | |
| Sep, 2024 | Amount | Grant - Amprion | Valuation |
investors |
|
| Sep, 2024 | Amount | Series A - Amprion | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amprion
Amprion has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Lilly, HHS and Foundry. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Scientists are empowered to reduce human suffering through capital and company-building expertise provided by the firm.
|
Founded Year | Domain | Location | |
|
Traditional pharmaceutical medicines are developed for multiple health fields.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amprion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amprion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amprion Comparisons
Competitors of Amprion
Amprion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ADx NeuroSciences, Cytox, PeopleBio R&D, Durin Technologies and ALA Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for assessing dementia risk are developed.
|
|
| domain | founded_year | HQ Location |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
In vitro diagnostic kits for multiple sclerosis detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amprion
Frequently Asked Questions about Amprion
When was Amprion founded?
Amprion was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Where is Amprion located?
Amprion is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is Amprion a funded company?
Amprion is a funded company, having raised a total of $11.76M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5.76M, raised on May 16, 2012.
What does Amprion do?
Amprion Diagnostics is engaged in developing diagnostic tests for neurodegenerative disorders such as Parkinsons, Lewy body dementia, and Alzheimers. The companys primary offering, SAAmplify-αSYN, is a validated test for detecting pathological α-synuclein in cerebrospinal fluid, providing biological clarity with autopsy-confirmed accuracy. Services are tailored for patients, clinicians, and biopharma partners to improve diagnosis and treatment decisions. Research partnerships are maintained to advance insights into disease biology across healthcare sectors.
Who are the top competitors of Amprion?
Amprion's top competitors include ADx NeuroSciences, PeopleBio R&D and Cytox.
What products or services does Amprion offer?
Amprion offers SAAmplify-αSYN.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.